Holen Sie sich die Stockscreener-App
11.68
3.09%
0.35
Handel nachbörslich:
11.66
-0.02
-0.17%
Schlusskurs vom Vortag:
$11.33
Offen:
$11.33
24-Stunden-Volumen:
1.17M
Relative Volume:
0.75
Marktkapitalisierung:
$550.01M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-0.8992
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
-4.03%
1M Leistung:
-14.12%
6M Leistung:
+43.84%
1J Leistung:
+87.18%
1-Tages-Spanne:
$11.04
$11.97
1-Wochen-Bereich:
$10.95
$13.09
52-Wochen-Spanne:
$5.00
$16.85
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
11.68 | 652.38M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
What data driven models say about Ginkgo Bioworks Holdings Inc.’s futureEntry Point & Step-by-Step Swing Trade Plans - Newser
How to read the order book for Ginkgo Bioworks Holdings Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - Newser
Visualizing Ginkgo Bioworks Holdings Inc. stock with heatmapsTrade Ideas & Daily Price Action Insights - Newser
Developing predictive dashboards with Ginkgo Bioworks Holdings Inc. data2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - Newser
How moving averages guide Ginkgo Bioworks Holdings Inc. trading2025 Key Lessons & Daily Technical Forecast Reports - Newser
How Ginkgo Bioworks Holdings Inc. stock performs during market volatility2025 Key Highlights & Consistent Return Investment Signals - Newser
Pattern recognition hints at Ginkgo Bioworks Holdings Inc. upsideJuly 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Is Ginkgo Bioworks Holdings Inc. stock reversal real or fakeMarket Risk Summary & Long-Term Capital Growth Ideas - Newser
Can Ginkgo Bioworks Holdings Inc. outperform under higher oil pricesWeekly Risk Report & Consistent Profit Trade Alerts - khodrobank.com
Published on: 2025-09-02 22:33:59 - Newser
Will Ginkgo Bioworks Holdings Inc. outperform small cap indexesJuly 2025 Action & Reliable Entry Point Alerts - khodrobank.com
A | Is Ginkgo Bioworks Holdings, Inc. a strong candidate for buy and holdJuly 2025 Action & Reliable Entry Point Alerts - khodrobank.com
Is Ginkgo Bioworks Holdings Inc. stock a falling knife or bargain buyJuly 2025 Movers & Long Hold Capital Preservation Tips - khodrobank.com
Should you avoid Ginkgo Bioworks Holdings Inc. stock right nowQuarterly Market Summary & Reliable Price Breakout Alerts - khodrobank.com
Using data models to predict Ginkgo Bioworks Holdings Inc. stock movementEarnings Growth Report & Technical Pattern Recognition Alerts - Newser
Will breakout in Ginkgo Bioworks Holdings Inc. lead to full recoveryJuly 2025 Spike Watch & Long-Term Investment Growth Plans - Newser
Ginkgo Bioworks: Structural Cost Issues Will Be Difficult To Resolve (DNA) - Seeking Alpha
What Fibonacci levels say about Ginkgo Bioworks Holdings Inc. reboundQuarterly Profit Report & Fast Entry and Exit Trade Plans - Newser
Is Ginkgo Bioworks Holdings Inc. a speculative investmentJuly 2025 Breakouts & Daily Price Action Insights - khodrobank.com
Will Ginkgo Bioworks Holdings Inc. be affected by tariffs2025 Key Lessons & Advanced Swing Trade Entry Plans - sundaytimes.kr
Volatility clustering patterns for Ginkgo Bioworks Holdings Inc.Weekly Loss Report & Low Drawdown Investment Ideas - Newser
Key metrics from Ginkgo Bioworks Holdings Inc.’s quarterly dataJuly 2025 Trends & Growth Oriented Trade Recommendations - Newser
Can Ginkgo Bioworks Holdings Inc. be recession proofJuly 2025 Snapshot & Weekly Setup with High ROI Potential - khodrobank.com
What makes Ginkgo Bioworks Holdings Inc. stock price move sharplyCPI Data & Weekly Breakout Stock Alerts - Newser
Can Ginkgo Bioworks Holdings Inc. sustain earnings growthQuarterly Investment Review & AI Driven Stock Reports - khodrobank.com
Ranking Ginkgo Bioworks Holdings Inc. among high performing stocks via toolsMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Is Ginkgo Bioworks Holdings Inc. a candidate for recovery playQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Is a relief rally coming for Ginkgo Bioworks Holdings Inc. holders2025 Top Decliners & AI Forecasted Entry and Exit Points - Newser
Combining price and volume data for Ginkgo Bioworks Holdings Inc.Take Profit & Low Drawdown Investment Ideas - Newser
Does Ginkgo Bioworks Holdings Inc. fit your quant trading modelWeekly Profit Analysis & Low Risk Profit Maximizing Plans - Newser
Ginkgo Bioworks Holdings Inc.’s volatility index tracking explainedJuly 2025 Recap & Weekly Market Pulse Alerts - Newser
Is Ginkgo Bioworks Holdings Inc. stock ready for a breakout2025 Trading Volume Trends & Community Trade Idea Sharing - Newser
Pattern recognition hints at Trio Petroleum Corp. upsideJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Will Ginkgo Bioworks Holdings Inc. stock recover after recent dropPortfolio Performance Summary & Free Long-Term Investment Growth Plans - Newser
Is Ginkgo Bioworks Holdings Inc. meeting your algorithmic filter criteriaMarket Growth Report & Free Long-Term Investment Growth Plans - Newser
Ginkgo Bioworks Holdings Inc. stock outlook for YEARWeekly Investment Summary & Free Real-Time Volume Trigger Notifications - Newser
Detecting price anomalies in Ginkgo Bioworks Holdings Inc. with AIJuly 2025 Momentum & Community Consensus Picks - Newser
Is now a turning point for Ginkgo Bioworks Holdings Inc.July 2025 Macro Moves & Safe Capital Growth Stock Tips - Newser
Earnings visualization tools for FOXOJuly 2025 Closing Moves & Low Risk Investment Opportunities - Newser
Combining machine learning predictions for Ginkgo Bioworks Holdings Inc.July 2025 Intraday Action & Verified Swing Trading Watchlists - Newser
Custom strategy builders for tracking Ginkgo Bioworks Holdings Inc.2025 Buyback Activity & Entry Point Confirmation Alerts - Newser
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):